Non-obese | Obese | P-valuea | |
---|---|---|---|
(n = 85) | (n = 85) | ||
Age, years | 36 (26–44) | 37 (27–44) | 0.97a |
Female, n (%) | 68 (80) | 68 (80) | 1.00b |
Anthropometric variables: | |||
Weight, kg | 58.6 (54–62.8) | 107.4 (95.6-123.2) | <0.001a |
Height, m | 160 (156–168) | 161 (154–167) | 0.82a |
BMI, kg/m2 | 22.9 (21.3-24.7) | 41.2 (38.5-45) | <0.001a |
Waist circumference, cm | 76 (71–81.2) | 117 (108.5-128) | <0.001a |
Neck circumference, cm | 31 (29–33) | 40 (37.8-42) | <0.001a |
Abdominal obesity, n (%) | 15 (17) | 84 (100) | <0.001b |
Metabolic variables: | |||
Fasting glucose, mg/dL | 86 (80–91) | 90 (83–97) | 0.002a |
Fasting insulin, mg/dL | 7.3 (5.8-9.8) | 19 (12.9-26.5) | <0.001a |
HOMA-IR | 1.6 (1.1-2.2) | 4.4 (2.9-6) | <0.001a |
Matsuda index | 3.9 (2.2-6.3) | 7.8 (5.2-11.1) | <0.001a |
Glucose intolerance, n (%) | 1 (1) | 25 (29) | <0.001b |
Triglycerides, mg/dL | 95 (73–131) | 138 (102–188.5) | <0.001a |
Cholesterol, mg/dL | 181 (164–203) | 173.8 (152.8-201.5) | 0.084a |
HDL, mg/dL | 53 (44–62) | 42 (35–50) | <0.001a |
LDL, mg/dL | 109 (89.5-122) | 101.4 (82.4-121.1) | 0.23a |
Metabolic syndrome, n (%) | 2 (2) | 33 (38) | <0.001b |
OSA risk: | |||
SACS, n (%) | 0 | 4 (4) | 0.121b |
Epworth, n (%) | 7 (8) | 18 (21) | 0.017b |